Review
Open access
Sep 2026
Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer
Clinical evidence that connects HT with PTC is summarized and how these two conditions interact are examined, aiming to provide a theoretical foundation for developing personalized therapies that target the tumor immune microenvironment (TIME) during HT.
Xin Lin, Zhi Chen, Dan-Dan Song et al.
· Frontiers in Endocrinology · 0 citations